Massimo E. Dottorini

2.7k total citations
27 papers, 1.3k citations indexed

About

Massimo E. Dottorini is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Massimo E. Dottorini has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Physiology. Recurrent topics in Massimo E. Dottorini's work include Thyroid Cancer Diagnosis and Treatment (16 papers), BRCA gene mutations in cancer (5 papers) and Radiation Dose and Imaging (5 papers). Massimo E. Dottorini is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (16 papers), BRCA gene mutations in cancer (5 papers) and Radiation Dose and Imaging (5 papers). Massimo E. Dottorini collaborates with scholars based in Italy, United States and France. Massimo E. Dottorini's co-authors include L Colombo, C Ravetto, G Lomuscio, J.E. Couette, Marie‐Gabrielle Dondon, Moncef Abbas, Per Hall, Martin Schlumberger, A. Vignati and Corrado Rubino and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and British Journal of Cancer.

In The Last Decade

Massimo E. Dottorini

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo E. Dottorini Italy 14 1.1k 580 260 206 204 27 1.3k
Michele Klain Italy 25 1.4k 1.3× 733 1.3× 451 1.7× 261 1.3× 128 0.6× 97 2.1k
H Gharib United States 16 1.4k 1.3× 906 1.6× 131 0.5× 289 1.4× 213 1.0× 26 1.7k
Rainer Görges Germany 24 1.4k 1.3× 583 1.0× 512 2.0× 332 1.6× 119 0.6× 85 1.8k
Toshiro Usa Japan 20 731 0.7× 182 0.3× 158 0.6× 143 0.7× 136 0.7× 43 1.3k
Wai-Fan Chan China 11 585 0.5× 630 1.1× 58 0.2× 142 0.7× 143 0.7× 13 1.0k
D. Drui France 18 461 0.4× 416 0.7× 114 0.4× 93 0.5× 83 0.4× 63 839
Megumu Hino Japan 18 438 0.4× 210 0.4× 117 0.5× 195 0.9× 113 0.6× 68 1.1k
Lars‐Erik Tisell Sweden 17 384 0.4× 404 0.7× 74 0.3× 206 1.0× 120 0.6× 23 975
Massimo Torlontano Italy 29 2.9k 2.6× 1.8k 3.2× 233 0.9× 314 1.5× 307 1.5× 44 3.2k
Anouk N.A. van der Horst‐Schrivers Netherlands 20 794 0.7× 594 1.0× 96 0.4× 314 1.5× 60 0.3× 58 1.3k

Countries citing papers authored by Massimo E. Dottorini

Since Specialization
Citations

This map shows the geographic impact of Massimo E. Dottorini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo E. Dottorini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo E. Dottorini more than expected).

Fields of papers citing papers by Massimo E. Dottorini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo E. Dottorini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo E. Dottorini. The network helps show where Massimo E. Dottorini may publish in the future.

Co-authorship network of co-authors of Massimo E. Dottorini

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo E. Dottorini. A scholar is included among the top collaborators of Massimo E. Dottorini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo E. Dottorini. Massimo E. Dottorini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubino, Carolé, Rodrigue S. Allodji, Stéphane Bardet, et al.. (2022). Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment. British Journal of Cancer. 127(12). 2118–2124. 5 indexed citations
2.
Gjerum, Le, Kristian Steen Frederiksen, Otto Mølby Henriksen, et al.. (2020). Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model. NeuroImage Clinical. 27. 102267–102267. 13 indexed citations
3.
Massa, Federico, Lucia Farotti, Paolo Eusebi, et al.. (2019). Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer’s Disease and Inconclusive First Biomarker. Journal of Alzheimer s Disease. 72(4). 1193–1207. 5 indexed citations
4.
Cascianelli, Silvia, Cristina Tranfaglia, Susanna Nuvoli, et al.. (2018). Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using 123I-FP-CIT brain SPET data by using an artificial neural network classifier, a classification tree (ClT).. PubMed. 20 Suppl. 165–165. 3 indexed citations
5.
Salvadori, Nicola, et al.. (2018). Case of posterior cortical atrophy (PCA) evolved to PCA-CBS. BMJ Case Reports. 2018. bcr–2018. 2 indexed citations
6.
Ramusino, Matteo Cotta, Daniele Altomare, Frédéric Assal, et al.. (2018). IC‐P‐006: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY). Alzheimer s & Dementia. 14(7S_Part_1). 1 indexed citations
7.
Salvatori, Massimo, Germano Perotti, Maria Felicia Villani, et al.. (2013). Determining the appropriate time of execution of an I-131 post-therapy whole-body scan. Nuclear Medicine Communications. 34(9). 900–908. 21 indexed citations
8.
Picco, Agnese, Maria Cristina Polidori, Michela Ferrara, et al.. (2013). Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. European Journal of Nuclear Medicine and Molecular Imaging. 41(4). 764–775. 28 indexed citations
9.
Dottorini, Massimo E. & Massimo Salvatori. (2013). Is radioiodine treatment for thyroid cancer a risk factor for second primary malignancies?. Clinical and Translational Imaging. 1(3). 205–216. 5 indexed citations
10.
Puxeddu, Efisio, et al.. (2010). Targeted therapies for advanced thyroid cancer. Current Opinion in Oncology. 23(1). 13–21. 17 indexed citations
11.
Salvatori, Massimo, Germano Perotti, Vittoria Rufini, Maria Lodovica Maussier, & Massimo E. Dottorini. (2004). Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?. Clinical Endocrinology. 61(6). 704–710. 23 indexed citations
12.
Dottorini, Massimo E., et al.. (2004). Surgery of thyroid cancer: twelve years' personal experience.. PubMed. 24(6). 348–53. 2 indexed citations
13.
Rubino, Corrado, Florent de Vathaire, Massimo E. Dottorini, et al.. (2003). Second primary malignancies in thyroid cancer patients. British Journal of Cancer. 89(9). 1638–1644. 432 indexed citations
14.
Ravetto, C, L Colombo, & Massimo E. Dottorini. (2000). Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma. Cancer. 90(6). 357–363. 227 indexed citations
15.
Ravetto, C, L Colombo, & Massimo E. Dottorini. (2000). Usefulness of fine‐needle aspiration in the diagnosis of thyroid carcinoma. Cancer. 90(6). 357–363. 11 indexed citations
16.
Guglielmi, Rinaldo, Claudio Maurizio Pacella, Massimo E. Dottorini, et al.. (1999). Severe Thyrotoxicosis Due to Hyperfunctioning Liver Metastasis from Follicular Carcinoma: Treatment with 131 I and Interstitial Laser Ablation. Thyroid. 9(2). 173–177. 33 indexed citations
17.
Dottorini, Massimo E., et al.. (1997). Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.. PubMed. 38(5). 669–75. 108 indexed citations
18.
Dottorini, Massimo E., Agnese Assi, Maria Sironi, et al.. (1996). Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer. 77(8). 1556–1565. 146 indexed citations
19.
Dottorini, Massimo E., et al.. (1995). Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.. PubMed. 36(1). 21–7. 109 indexed citations
20.
Todisco, Tommaso, et al.. (1984). Laryngeal Cancer: Long-Term FolIow-Up of Respiratory Functions after Laryngectomy. Respiration. 45(3). 303–315. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026